New Research Released on CEL-SCI Corporation (CVM-NYSE)
An updated Executive Informational Overview (EIO) is now available on CEL-SCI Corporation, a clinical-stage ...
New Research Released on CEL-SCI Corporation (CVM-NYSE)
An Executive Informational Overview (EIO) is now available on CEL-SCI Corporation, a clinical-stage ...
CEL-SCI Continues Advancing to the Start of Phase III Trials for Multikine
This morning, CEL-SCI Corp. (CVM-NYSE Amex) announced the completion of its clinical investigator meeting ...
Recent Financial Results and Updates
Last week, several companies within our coverage universe released financial results and corporate updates, ...
A Solid Start to 2011
As we kick off the New Year, many companies within our Coverage Universe are showing a positive start to ...
Mid-Week News Highlights (12/6-12/8) from CRA’s Coverage Universe
News from our coverage universe this week includes Johnson & Johnson’s bid to buy Crucell for $2.3 ...
CEL-SCI’s progress toward the start of its Phase III trial
CEL-SCI Corporation (CVM-NYSE Amex) is advancing its Phase III clinical trial of Multikine®, CEL-SCI’s lead ...